Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave / RW455
Boston, MA 02215Phone+1 617-667-2100
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Boston University Medical CenterChief Residency, Internal Medicine, 2011 - 2012- Boston University Medical CenterResidency, Internal Medicine, 2008 - 2011
Rutgers New Jersey Medical SchoolClass of 2008
University of PennsylvaniaBS, Economics / Biochemistry, 2000 - 2004
Certifications & Licensure
MA State Medical License 2011 - 2026
Publications & Presentations
PubMed
- 1 citationsBotensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, Gabriel Mednick, Chloe Delepine
Cancer Discovery. 2024-12-02 - 4 citationsElevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.Subodh Kumar, Jiangning Zhao, Srikanth Talluri, Leutz Buon, Shidai Mu
Gastroenterology. 2023-08-01 - 17 citationsThe CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.Ang Li, Nicole M. Kuderer, Chih-Yuan Hsu, Yu Shyr, Jeremy L. Warner
Journal of Thrombosis and Haemostasis. 2021-07-14
Press Mentions
- CDK 4/6 Inhibitor, Ribociclib, with Adjuvant Endocrine Therapy for ER-Positive Breast Cancer (LEADER)September 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
